Results for tag: "Auryxia"

Auryxia is a drug used to treat endocrine and metabolic disorders. It is a phosphate binder, which helps to reduce the amount of phosphate in the blood. It is used to treat hyperphosphatemia, a condition in which there is an abnormally high level of phosphate in the blood. Auryxia is also used to treat secondary hyperparathyroidism, a condition in which the parathyroid glands produce too much parathyroid hormone. It is also used to treat chronic kidney disease, a condition in which the kidneys are unable to filter waste from the blood. The Auryxia market is composed of pharmaceutical companies that produce and market the drug. These companies include Keryx Biopharmaceuticals, Akebia Therapeutics, and Vifor Pharma. They are responsible for the research, development, and marketing of Auryxia. They also provide support to healthcare professionals and patients who use the drug. Show Less Read more